Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/ Gastroesophageal Adenocarcinoma
ONCOLOGY · 12.04.2023 · (3704) · 176-183
DOI: 10.46883/2023.25920992 ↗Kurz gefasst
Fachartikel in der Zeitschrift ONCOLOGY, online erschienen am 27.04.2023. Verfasst von Daniel Vt Catenacci und 31 weiteren Autor:innen. Hauptthemen laut MEDLINE: Adenocarcinoma, Circulating Tumor DNA, Stomach Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Zitieren
APA
Catenacci, D. V., Kang, Y. K., Uronis, H. E., Lee, K. W., Ng, M. C., Enzinger, P. C., Park, S. H., Gold, P. J., Lacy, J., Hochster, H. S., Oh, S. C., Kim, Y. H., Marrone, K. A., Kelly, R. J., Juergens, R. A., Kim, J. G., Alcindor, T., Sym, S. J., Song, E. K., …, & Park, H. (2023). Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/ Gastroesophageal Adenocarcinoma. ONCOLOGY, 176-183. https://doi.org/10.46883/2023.25920992
Vancouver
Catenacci DV, Kang YK, Uronis HE, Lee KW, Ng MC, Enzinger PC, et al. Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/ Gastroesophageal Adenocarcinoma. ONCOLOGY. 2023:176-183. doi:10.46883/2023.25920992
BibTeX
@article{Catenacci2023,
author = {Catenacci, Daniel Vt and Kang, Yoon-Koo and Uronis, Hope E and Lee, Keun-Wook and Ng, Matthew Ch and Enzinger, Peter C and Park, Se Hoon and Gold, Philip J and Lacy, Jill and Hochster, Howard S and Oh, Sang Cheul and Kim, Yeul Hong and Marrone, Kristen A and Kelly, Ronan J and Juergens, Rosalyn A and Kim, Jong Gwang and Alcindor, Thierry and Sym, Sun Jin and Song, Eun-Kee and Chee, Cheng Ean and Chao, Yee and Kim, Sunnie and Oh, Do-Youn and Yen, Jennifer and Odegaard, Justin I and Lagow, Errin and Li, Daner and Sun, Jichao and Kaminker, Patrick and Moore, Paul A and Rosales, Minori Koshiji and Park, Haeseong},
title = {Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/ Gastroesophageal Adenocarcinoma},
journal = {ONCOLOGY},
year = {2023},
number = {3704},
pages = {176--183},
doi = {10.46883/2023.25920992}
}
EUVIMED